SGLT2 Inhibitors Reduce Alzheimer’s Risk by 43%: New Study Findings

Recent clinical research indicates that patients prescribed SGLT2 inhibitors—a class of medication primarily used to treat type 2 diabetes—may experience a significantly lower risk of developing Alzheimer’s disease. Data suggest that the anti-inflammatory and metabolic benefits of these drugs could play a protective role in neurological health, potentially reducing the incidence of dementia by 43% … Read more

PCOS Officially Becomes PMOS: 5 Essential Facts You Need to Know

In the evolving landscape of reproductive health, terminology often shifts to better reflect the clinical reality of patient experiences. Recently, discussions regarding the nomenclature of Polycystic Ovary Syndrome (PCOS)—frequently referred to by its acronym—have sparked a global conversation about precision in medical diagnostics. As we navigate these updates, it is essential for patients and clinicians … Read more